Trial · NCT00121108
Adverse events284
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 284
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Dacryostenosis congenital | Congenital, familial and genetic disorders | PLACEBO | 4 | 708 | 4 |
| other | Dacryostenosis congenital | Congenital, familial and genetic disorders | MOTAVIZUMAB | 23 | 1,414 | 24 |
| other | Cerumen impaction | Ear and labyrinth disorders | PLACEBO | 39 | 708 | 40 |
| other | Cerumen impaction | Ear and labyrinth disorders | MOTAVIZUMAB | 81 | 1,414 | 94 |
| other | Ear pain | Ear and labyrinth disorders | PLACEBO | 8 | 708 | 8 |
| other | Ear pain | Ear and labyrinth disorders | MOTAVIZUMAB | 24 | 1,414 | 24 |
| other | Conjunctivitis | Eye disorders | PLACEBO | 136 | 708 | 152 |
| other | Conjunctivitis | Eye disorders | MOTAVIZUMAB | 271 | 1,414 | 303 |
| other | Eye discharge | Eye disorders | PLACEBO | 12 | 708 | 12 |
| other | Eye discharge | Eye disorders | MOTAVIZUMAB | 21 | 1,414 | 21 |
| other | Abdominal pain | Gastrointestinal disorders | PLACEBO | 13 | 708 | 13 |
| other | Abdominal pain | Gastrointestinal disorders | MOTAVIZUMAB | 26 | 1,414 | 26 |
| other | Constipation | Gastrointestinal disorders | PLACEBO | 57 | 708 | 61 |
| other | Constipation | Gastrointestinal disorders | MOTAVIZUMAB | 97 | 1,414 | 107 |
| other | Diarrhoea | Gastrointestinal disorders | PLACEBO | 106 | 708 | 130 |
| other | Diarrhoea | Gastrointestinal disorders | MOTAVIZUMAB | 196 | 1,414 | 230 |
| other | Enteritis | Gastrointestinal disorders | PLACEBO | 4 | 708 | 4 |
| other | Enteritis | Gastrointestinal disorders | MOTAVIZUMAB | 17 | 1,414 | 17 |
| other | Gastrooesophageal reflux disease | Gastrointestinal disorders | PLACEBO | 10 | 708 | 10 |
| other | Gastrooesophageal reflux disease | Gastrointestinal disorders | MOTAVIZUMAB | 19 | 1,414 | 19 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00121108/events